These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36800625)

  • 81. Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis.
    Deconinck E; Petrella T; Garnache Ottou F
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):491-500. PubMed ID: 32336414
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Clinical Characteristics of CD4
    He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Pemmaraju N; Sweet KL; Stein AS; Wang ES; Rizzieri DA; Vasu S; Rosenblat TL; Brooks CL; Habboubi N; Mughal TI; Kantarjian H; Konopleva M; Lane AA
    J Clin Oncol; 2022 Sep; 40(26):3032-3036. PubMed ID: 35820082
    [No Abstract]   [Full Text] [Related]  

  • 84. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
    Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
    Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
    Pemmaraju N; Gupta V; Thompson MA; Lane AA
    Curr Hematol Malig Rep; 2016 Dec; 11(6):462-467. PubMed ID: 27492117
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.
    Economides MP; Konopleva M; Pemmaraju N
    Ther Adv Hematol; 2019; 10():2040620719874733. PubMed ID: 31579499
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Xue T; Budde LE
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):575-587. PubMed ID: 32336421
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Alfayez M; Konopleva M; Pemmaraju N
    Expert Opin Biol Ther; 2020 Feb; 20(2):115-123. PubMed ID: 31801379
    [No Abstract]   [Full Text] [Related]  

  • 89. Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.
    Pemmaraju N; Utengen A; Gupta V; Thompson MA; Lane AA
    Curr Hematol Malig Rep; 2017 Dec; 12(6):592-597. PubMed ID: 29064025
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
    Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N
    Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Detection of Minimal Bone Marrow involvement of Blastic Plasmacytoid Dendritic Cell Neoplastic Cells - CD303 immunostaining as a diagnostic tool.
    Ohe R; Aung NY; Shiono Y; Utsunomiya A; Kabasawa T; Tamazawa N; Tamura Y; Kato T; Yamada A; Hasegawa S; Aizawa K; Inokura K; Ito S; Toubai T; Kato Y; Tsunoda T; Onami K; Suzuki T; Ishizawa K; Yamakawa M
    J Clin Exp Hematop; 2018 Mar; 58(1):1-9. PubMed ID: 29415975
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.
    Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS
    Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Blastic plasmacytoid dendritic cell neoplasm with a history of cytopenia: A case report.
    Yan M; Wang W; Cen X; Wang L; Sun Y; Wang B; Ou J; Nong L; Ren H; Zhu P; Wang M
    Diagn Cytopathol; 2020 Nov; 48(11):1102-1106. PubMed ID: 32374950
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies.
    Mehra S; Taylor J
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334635
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN-Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community.
    Pemmaraju N; Utengen A; Gupta V; Thompson MA; Lane AA
    Curr Hematol Malig Rep; 2018 Dec; 13(6):581-587. PubMed ID: 30338458
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
    Purkait S; Gupta S; Bakhshi S; Mallick S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
    Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
    Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Davis JA; Rizzieri DA; Lane AA; Taylor J; Faisal MS; Vasu S; Soong D; Li H; Herbst A; Greenwell IB
    Leuk Lymphoma; 2022 Nov; 63(11):2757-2759. PubMed ID: 35727174
    [No Abstract]   [Full Text] [Related]  

  • 100. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review.
    Kim MJ; Nasr A; Kabir B; de Nanassy J; Tang K; Menzies-Toman D; Johnston D; El Demellawy D
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):528-537. PubMed ID: 28906324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.